Insmed Incorporated (INSM)

CIK 0001104506 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 8-K (2026-08-06) · 99.1 · 99.2
Q1-2026 8-K (2026-05-07) · 99.1 · 99.2
Latest FY-2025 8-K (2026-02-19) · 99.1 · 99.2
Q3-2025 8-K (2025-10-30) · 99.1 · 99.2
Q2-2025 8-K (2025-08-07) · 99.1 · 99.2
Q1-2025 8-K (2025-05-08) · 99.1 · 99.2
FY-2024 8-K (2025-02-20) · 99.1 · 99.2
Q3-2024 8-K (2024-10-31) · 99.1
Q2-2024 8-K (2024-08-08) · 99.1
Q1-2024 8-K (2024-05-09) · 99.1 · 99.2
FY-2023 8-K (2024-02-22) · 99.1
Q3-2023 8-K (2023-10-26) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Audit Information
—
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Comprehensive Loss
Consolidated Statements of Shareholders' Equity
Consolidated Statements of Shareholders' Equity (deficit) (unaudited)
—
Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows (P)
Consolidated Statements of Shareholders' Equity (P)
—
Notes
Accounts Payable and Accrued Liabilities
Acquisitions
Commitments and Contingencies
Cybersecurity Risk Management and Strategy Disclosure
—
Debt
Fair Value Measurements
Fixed Assets, Net
Income Taxes
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Intangibles, Net and Goodwill
Inventory
Leases
License and Other Agreements
—
Pay Vs Performance Disclosure
Product Revenues, Net
Retirement Plan
—
Royalty Financing Agreement
Segment Reporting
Shareholders' Equity
Stock-based Compensation
Subsequent Events
—
Summary of Significant Accounting Policies
The Company and Basis of Presentation